Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes [Phase 4]
This update reports the results of a Phase 4 trial comparing repaglinide to metformin in non-obese adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet [Phase 4]
A Phase 4 clinical trial comparing metformin versus repaglinide in non-obese adults with Type 2 diabetes inadequately controlled by diet has…
-
CLINICAL_TRIALS trial_result · 2008-12-04Clinical Trial Update: Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluated escalating doses of a novel viscous polysaccharide for reducing postprandial blood glucose, and t…
-
CLINICAL_TRIALS trial_result · 2008-12-03Clinical Trial Update: Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) [Phase 4]
Phase 4 study update evaluating phenotypes in insulin-naive patients with type 2 diabetes treated with Lantus (insulin glargine).
-
FDA approval · 2008-11-28FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-11-28FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2008-11-28FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for Insulin aspart protamine and insulin aspart mix 70/30 (Novo Nordisk) to continue marketing this …
-
CLINICAL_TRIALS trial_result · 2008-11-27Clinical Trial Update: Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes [Phase 3]
Long-term safety findings from a Phase 3 trial evaluating vildagliptin 100 mg once daily in patients with Type 2 diabetes mellitus.
-
FDA approval · 2008-11-24FDA Approved: ACARBOSE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for acarbose submitted by Hikma Pharmaceuticals USA Inc., under ANDA078470. This represents regu…
-
FDA approval · 2008-11-21FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic glyburide and metformin hydrochloride combination from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2008-11-21Clinical Trial Update: Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria [Phase 2]
A Phase IIa trial evaluating the efficacy and safety of SPP635 in hypertensive and type 2 diabetic patients with albuminuria has completed.
-
CLINICAL_TRIALS research · 2008-11-14Clinical Trial Update: Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus [Phase 4]
This is a clinical trial update describing prospective randomized Phase 4 trials assessing gastric bypass surgery in patients with Type 2 di…
-
CLINICAL_TRIALS research · 2008-11-13Clinical Trial Update: Effect of Januvia on Ghrelin and Other Gut Hormones in Patients With Diabetes
This clinical trial update investigates the effects of Januvia (sitagliptin) on ghrelin and other gut hormones in patients with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2008-11-13Clinical Trial Update: A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes [Phase 2]
A Phase 2b trial evaluating DIO-902 in addition to standard therapy for Type 2 diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2008-11-11Clinical Trial Update: Mediterranean Diet and Postprandial Lipemia [NA]
This completed clinical trial evaluated whether adopting a Mediterranean diet affects postprandial lipemia in individuals with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2008-11-03Clinical Trial Update: Glitazones and Endothelial Function (GATE) [Phase 3]
Phase 3 trial GATE evaluating glitazones and endothelial function in type 2 diabetes mellitus was terminated. The snippet does not provide t…
-
FDA approval · 2008-10-31FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for metformin hydrochloride (generic) from Viona Pharmaceuticals Inc, indicating an approved update …
-
FDA approval · 2008-10-29FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental ANDA for Metformin Hydrochloride from Aurobindo Pharma Limited, authorizing the generic product's market entry.
-
FDA approval · 2008-10-27FDA Approved: GLUCOTROL XL — Supplemental Application (Roerig)
FDA approved a supplemental application for GLUCOTROL XL (glipizide) submitted by Roerig.
-
FDA approval · 2008-10-24FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) from Sanofi-aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2008-10-23Clinical Trial Update: Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions [NA]
Clinical trial update reporting the completion of a bioequivalence study of metformin HCl 750 mg extended-release tablets under non-fasting …
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients [Phase 3]
A Phase 3 double-blind study compared mitiglinide with nateglinide in patients with Type 2 diabetes and has completed. The update confirms t…
-
CLINICAL_TRIALS trial_result · 2008-10-21Clinical Trial Update: Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
Completed bioequivalence study evaluating Glucotrol XL 2.5 mg extended-release tablets in adults with type 2 diabetes mellitus. The trial as…
-
FDA approval · 2008-10-20FDA Approved: RIOMET — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved RIOMET (metformin hydrochloride) under the original NDA for Sun Pharmaceutical Industries, establishing a new metformin pro…
-
FDA approval · 2008-10-20FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Januvia (sitagliptin) filed by Merck Sharp & Dohme LLC.